Skip to main content
Log in

Capping drugs: Development of prodrugs

  • General Article
  • Published:
Resonance Aims and scope Submit manuscript

Conclusion

It is clear from the foregoing, that the development of prodrugs promises to be a very effective method for treatment of diseases in the future. This approach has several advantages over conventional drug administration. Site specificity is central to the prodrug development strategy. Even though at present prodrugs are not prevalent in clinical use, in future there will be prodrugs for every known drug to make them effective in treatment. Drug discovery and prodrug development appear to be complementary for the generation of target specific medicines of future. At present the research in this area is at a nascent stage due to lack of information regarding all the enzymes or receptors most suitable for targeting purposes. As the unravelling of the microbiological details of the affected targets become clear, prodrug development will surely decrease side/toxic effects of drugs and also trigger development of more potent primary drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Suggested Reading

  1. P K Banerjee and G L Amidon,Design of Prodrugs, (Ed.)H Bundgaard, New York: Elsevier; pp. 93–133, 1985.

    Google Scholar 

  2. A Albert,Nature, 182, p. 421, 1958.

    Article  Google Scholar 

  3. F M H de Groot, E W P Damen and H W Scheeren,Current Medicinal Chemistry 8, p.1093, 2001.

    Google Scholar 

  4. E W P Damen, F M H de Groot and H W Scheeren,Exp. Opin. Ther. Patents, 11, p. 651, 2001.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Surya Prakash Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rao, H.S.P. Capping drugs: Development of prodrugs. Reson 8, 19–27 (2003). https://doi.org/10.1007/BF02835647

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02835647

Keywords

Navigation